Side Effects of Newer Antipsychotics in Older Adults
Schizophrenia, Alzheimer's Disease, Dementia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring Antipsychotic, Diabetes, Hyperlipidemia, Stroke
Eligibility Criteria
Inclusion Criteria: DSM-IV diagnosis of a disease or disorder that requires treatment with an atypical antipsychotic medication Exclusion Criteria: N/A
Sites / Locations
- University of California, San Diego
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
1: Risperdal
3: Aripiprazole
4: Olanzapine
Participants randomized to this arm will be prescribed risperdal. They will continue to be followed by their psychiatrist. In addition, they will take part in ongoing biological, cognitive, and psycho-social assessments with study staff.
Participants randomized to this arm will be prescribed aripiprazole. They will continue to be followed by their psychiatrist. In addition, they will take part in ongoing biological, cognitive, and psycho-social assessments with study staff.
Participants randomized to this arm will be prescribed olanzapine. They will continue to be followed by their psychiatrist. In addition, they will take part in ongoing biological, cognitive, and psycho-social assessments with study staff.